Improved and adopted murine models to combat pulmonary aspergillosis

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

The insufficient basic and clinical knowledge about invasive mold infections necessitated to review aspergillosis rodent models. The scope of this review has two major aspects. (1) It briefly summarizes Aspergillus toxicoses, the adverse effects of Aspergillus mycotoxins, the virulence factors of Aspergillus fumigatus, and how mild Aspergillus infections can turn to immunosuppressive diseases, ultimately to lethal invasive pulmonary aspergillosis. (2) The second major aspect of the review deals with earlier and recent murine models of pulmonary aspergillosis. Particular attention will be paid to the development of unified and generally applicable methods to detect, follow, and combat aspergillosis by medical treatments. Additionally, the review raises the question of responsibility regarding the application of immunosuppressive agents that initiate, contribute, and aggravate aspergillosis. Future studies of immunosuppression by chemical agents impacting aspergillosis deserve more studies.

Original languageEnglish
Pages (from-to)1-11
Number of pages11
JournalApplied Microbiology and Biotechnology
DOIs
Publication statusAccepted/In press - Jun 17 2018

Fingerprint

Pulmonary Aspergillosis
Aspergillosis
Aspergillus
Immunosuppressive Agents
Invasive Pulmonary Aspergillosis
Aspergillus fumigatus
Mycotoxins
Virulence Factors
Infection
Immunosuppression
Rodentia
Fungi

Keywords

  • A. fumigatus
  • Aspergillosis
  • Aspergillus mycotoxins
  • Diagnosis and therapy
  • Organs impacted
  • Standardization of murine models

ASJC Scopus subject areas

  • Biotechnology
  • Applied Microbiology and Biotechnology

Cite this

Improved and adopted murine models to combat pulmonary aspergillosis. / Bánfalvi, G.

In: Applied Microbiology and Biotechnology, 17.06.2018, p. 1-11.

Research output: Contribution to journalArticle

@article{f443aaaaa0bd4672a6b4fbdad1b392fd,
title = "Improved and adopted murine models to combat pulmonary aspergillosis",
abstract = "The insufficient basic and clinical knowledge about invasive mold infections necessitated to review aspergillosis rodent models. The scope of this review has two major aspects. (1) It briefly summarizes Aspergillus toxicoses, the adverse effects of Aspergillus mycotoxins, the virulence factors of Aspergillus fumigatus, and how mild Aspergillus infections can turn to immunosuppressive diseases, ultimately to lethal invasive pulmonary aspergillosis. (2) The second major aspect of the review deals with earlier and recent murine models of pulmonary aspergillosis. Particular attention will be paid to the development of unified and generally applicable methods to detect, follow, and combat aspergillosis by medical treatments. Additionally, the review raises the question of responsibility regarding the application of immunosuppressive agents that initiate, contribute, and aggravate aspergillosis. Future studies of immunosuppression by chemical agents impacting aspergillosis deserve more studies.",
keywords = "A. fumigatus, Aspergillosis, Aspergillus mycotoxins, Diagnosis and therapy, Organs impacted, Standardization of murine models",
author = "G. B{\'a}nfalvi",
year = "2018",
month = "6",
day = "17",
doi = "10.1007/s00253-018-9161-8",
language = "English",
pages = "1--11",
journal = "Applied Microbiology and Biotechnology",
issn = "0175-7598",
publisher = "Springer Verlag",

}

TY - JOUR

T1 - Improved and adopted murine models to combat pulmonary aspergillosis

AU - Bánfalvi, G.

PY - 2018/6/17

Y1 - 2018/6/17

N2 - The insufficient basic and clinical knowledge about invasive mold infections necessitated to review aspergillosis rodent models. The scope of this review has two major aspects. (1) It briefly summarizes Aspergillus toxicoses, the adverse effects of Aspergillus mycotoxins, the virulence factors of Aspergillus fumigatus, and how mild Aspergillus infections can turn to immunosuppressive diseases, ultimately to lethal invasive pulmonary aspergillosis. (2) The second major aspect of the review deals with earlier and recent murine models of pulmonary aspergillosis. Particular attention will be paid to the development of unified and generally applicable methods to detect, follow, and combat aspergillosis by medical treatments. Additionally, the review raises the question of responsibility regarding the application of immunosuppressive agents that initiate, contribute, and aggravate aspergillosis. Future studies of immunosuppression by chemical agents impacting aspergillosis deserve more studies.

AB - The insufficient basic and clinical knowledge about invasive mold infections necessitated to review aspergillosis rodent models. The scope of this review has two major aspects. (1) It briefly summarizes Aspergillus toxicoses, the adverse effects of Aspergillus mycotoxins, the virulence factors of Aspergillus fumigatus, and how mild Aspergillus infections can turn to immunosuppressive diseases, ultimately to lethal invasive pulmonary aspergillosis. (2) The second major aspect of the review deals with earlier and recent murine models of pulmonary aspergillosis. Particular attention will be paid to the development of unified and generally applicable methods to detect, follow, and combat aspergillosis by medical treatments. Additionally, the review raises the question of responsibility regarding the application of immunosuppressive agents that initiate, contribute, and aggravate aspergillosis. Future studies of immunosuppression by chemical agents impacting aspergillosis deserve more studies.

KW - A. fumigatus

KW - Aspergillosis

KW - Aspergillus mycotoxins

KW - Diagnosis and therapy

KW - Organs impacted

KW - Standardization of murine models

UR - http://www.scopus.com/inward/record.url?scp=85048601734&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85048601734&partnerID=8YFLogxK

U2 - 10.1007/s00253-018-9161-8

DO - 10.1007/s00253-018-9161-8

M3 - Article

AN - SCOPUS:85048601734

SP - 1

EP - 11

JO - Applied Microbiology and Biotechnology

JF - Applied Microbiology and Biotechnology

SN - 0175-7598

ER -